Regeneron Pharmaceuticals Inc at Piper Jaffray Healthcare Conference Transcript
We're going to go ahead and get started. My name is Chris Raymond. I'm a senior biotech analyst here at Piper Jaffray. It's my pleasure to introduce and kick off our 31st Annual Healthcare Conference for Piper Jaffray with Regeneron. Joining us today, we have Bob Landry, Regeneron's CFO. And also on the stage with us is Justin Holko, who heads up the IR group. So thanks for joining us.
Just to go over the format, this is a fireside chat. We try to keep this informal. So if anybody in the audience has questions, please raise your hands. We'll make sure we get them asked and answered. But first, I think we're going to go into a little bit of introduction from Bob, and then we'll kick it off. So thank you.
Sure. So Chris, thanks for being here. Thanks for the invite. Regeneron's always happy to come to your event. So I've been at Regeneron for 6 years. I am the CFO.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |